UCB at American Epilepsy Society meeting
Posted by
04-Dec-2014
More than 5,000 of the world's leading epilepsy professionals will attend the 68th Annual Meeting of the American Epilepsy Society in Seattle from December 5 to 9. UCB is looking forward to joining the broader epilepsy community in learning about the latest research and advances in care for people living with epilepsy.
The American Epilepsy Society is one of the oldest neurological professional organisations in the US. In keeping with its mission – 'Working towards a world without epilepsy' – the Society encourages experts to share scientific and clinical knowledge about epilepsy in children and adults.
UCB is also pleased to contribute to this annual meeting through an exhibit booth and 24 UCB-sponsored presentations. These include a late-breaking abstract with data from a phase three clinical trial evaluating an investigational medicine for the adjunctive treatment of partial-onset seizures in adults with epilepsy. The presentations also include results from UCB’s innovative epilepsy research collaborations with experts in industry, government and academia.
AES will also be an opportunity for UCB to showcase its support of programmes for people living with epilepsy and their loved ones. Visitors to the UCB booth in the exhibit hall will have the opportunity to meet some of the seizure response dogs from Canine Assistants. UCB is the proud sole sponsor of Canine Assistants seizure response dogs, a programme that provides specially trained service dogs to people with epilepsy. Since 2003, UCB’s support of this programme has covered the training and lifetime veterinary care for seizure response dogs for more than 250 people living with epilepsy.
UCB will also be highlighting the 10 years of the UCB Family Epilepsy Scholarship Program™ in its booth. UCB has awarded more than $1.5 million in educational grants to more than 300 people living with epilepsy, family members and caregivers who demonstrate academic ambition and personal achievement and are pursuing higher education.
UCB has a rich heritage in epilepsy with over 20 years of experience in the research and development of antiepileptic drugs and a longstanding history of support unique programmes for people with epilepsy and their families. The research and programmes that will be featured at the AES meeting in Seattle illustrate our dedication to collaborating with the epilepsy community to raise the standard of care for the patients we all serve.
The American Epilepsy Society is one of the oldest neurological professional organisations in the US. In keeping with its mission – 'Working towards a world without epilepsy' – the Society encourages experts to share scientific and clinical knowledge about epilepsy in children and adults.
UCB is also pleased to contribute to this annual meeting through an exhibit booth and 24 UCB-sponsored presentations. These include a late-breaking abstract with data from a phase three clinical trial evaluating an investigational medicine for the adjunctive treatment of partial-onset seizures in adults with epilepsy. The presentations also include results from UCB’s innovative epilepsy research collaborations with experts in industry, government and academia.
AES will also be an opportunity for UCB to showcase its support of programmes for people living with epilepsy and their loved ones. Visitors to the UCB booth in the exhibit hall will have the opportunity to meet some of the seizure response dogs from Canine Assistants. UCB is the proud sole sponsor of Canine Assistants seizure response dogs, a programme that provides specially trained service dogs to people with epilepsy. Since 2003, UCB’s support of this programme has covered the training and lifetime veterinary care for seizure response dogs for more than 250 people living with epilepsy.
UCB will also be highlighting the 10 years of the UCB Family Epilepsy Scholarship Program™ in its booth. UCB has awarded more than $1.5 million in educational grants to more than 300 people living with epilepsy, family members and caregivers who demonstrate academic ambition and personal achievement and are pursuing higher education.
UCB has a rich heritage in epilepsy with over 20 years of experience in the research and development of antiepileptic drugs and a longstanding history of support unique programmes for people with epilepsy and their families. The research and programmes that will be featured at the AES meeting in Seattle illustrate our dedication to collaborating with the epilepsy community to raise the standard of care for the patients we all serve.
Leave a Comment